SEARCH RESULTS FOR: (*what is fsi pso billmatrix*)(10991 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

The assay is designed for detection of potentially detrimental antibody against HLA antigens in the serum of pre- and post-transplant organ recipients.
ONE LAMBDA, INC.
N/A
In Commercial Distribution

  • 00812117012513 ()
LATM10X5

  • HLA class I & II antibody screening IVD, kit, multiplex
The assay is designed for detection of potentially detrimental antibody against HLA antigens in the serum of pre- and post-transplant organ recipients.
ONE LAMBDA, INC.
N/A
In Commercial Distribution

  • 00812117012506 ()
LATM120

  • HLA class I & II antibody screening IVD, kit, multiplex
The assay is designed for detection of potentially detrimental antibody against HLA antigens in the serum of pre- and post-transplant organ recipients.
ONE LAMBDA, INC.
N/A
In Commercial Distribution

  • 00812117012490 ()
LAT1288

  • HLA class I & II antibody screening IVD, kit, multiplex
The assay is designed for detection of potentially detrimental antibody against HLA antigens in the serum of pre- and post-transplant organ recipients.
ONE LAMBDA, INC.
N/A
In Commercial Distribution

  • 00812117012483 ()
LAT1240

  • HLA class I & II antibody screening IVD, kit, multiplex
The assay is designed for detection of potentially detrimental antibody against HLA antigens in the serum of pre- and post-transplant organ recipients.
ONE LAMBDA, INC.
N/A
In Commercial Distribution

  • 00812117012476 ()
LAT240

  • HLA class I & II antibody screening IVD, kit, multiplex
The assay is designed for detection of potentially detrimental antibody against HLA antigens in the serum of pre- and post-transplant organ recipients.
ONE LAMBDA, INC.
N/A
In Commercial Distribution

  • 00812117012469 ()
LAT140X2

  • HLA class I & II antibody screening IVD, kit, multiplex
The assay is designed for detection of potentially detrimental antibody against HLA antigens in the serum of pre- and post-transplant organ recipients.
ONE LAMBDA, INC.
N/A
In Commercial Distribution

  • 00812117012452 ()
LAT140

  • HLA class I & II antibody screening IVD, kit, multiplex
Haemostatic Gauze: Haemostatic gauze coated with Celox granules. Device is indicated to control moderate to severe bleeding. For temporary external use only.
MEDTRADE PRODUCTS LIMITED
FG08838021
In Commercial Distribution

  • 75060206630153 ()
  • 15060206630151 ()

  • Length: 5 Feet
  • Width: 3 Inch
  • Gauze size 3in x 5ft
FG08838021

  • Chitosan haemostatic agent, professional, non-bioabsorbable
L-Mesitran Tulle are wound dressings for the use on wounds. L-Mesitran Tulle is a non-adherent polyethylene dressing impregnated with L-Mesitran Soft gel.
Theo Manufacturing B.V.
318.10.US
In Commercial Distribution

  • 08717249680833 ()
  • 08717249680505 ()

  • Length: 4 Inch
  • Width: 4 Inch


  • Medical honey liquid barrier dressing
NovoSorb® MTX is a biodegradable polyurethane porous matrix supplied in various sizes, ranging from 4cm2 to 800cm2. NovoSorb® MTX is a single use, terminally sterilized device, individually packed in a transparent polymer pouch enclosed in an aluminized pouch contained in a cardboard envelope. NovoSorb® MTX can be used where a delay in normal wound healing is not considered necessary by the treating physician, e.g., definitive wound closure by secondary intention.
POLYNOVO BIOMATERIALS PTY LIMITED
MTX-0505
In Commercial Distribution

  • 09349155002608 ()
  • 09349155002615 ()
  • 09349155002622 ()

  • Width: 5 Centimeter
  • Length: 5 Centimeter


  • Synthetic wound matrix dressing
< 1 ... 42 43 44 45 46 ... 1000 >